-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.ISIN CA89620X5064
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 6,69 EUR -1,53%
ETFs die in Trillium Therapeutics Inc investieren
Dir gefallen die Informationen zu Trillium Therapeutics Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu Trillium Therapeutics Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Trillium Therapeutics Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Trillium Therapeutics Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
69 News & Informationen zur Trillium Therapeutics Inc Aktie
SHAREHOLDER ALERT: WeissLaw LLP Reminds TRIL, SIC, SAFM, and GRA Shareholders About Its Ongoing Investigations
NEW YORK, Aug. 30, 2021 /PRNewswire/ — If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your… | August 30, 2021
SHAREHOLDER ALERT: WeissLaw LLP Reminds TRIL, SIC, SAFM, and GRA Shareholders About Its Ongoing Investigations
/PRNewswire/ — If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this…
INVESTIGATION: Halper Sadeh LLP Investigates LMRK, HFC, NLOK, TRIL, LDL; Shareholders are Encouraged to Contact the Firm
/PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Landmark Infrastructure Partners LP…
Pfizer's Covid Technology May Have Cancer Applications
GuruFocus Article or News written by Barry Cohen and the topic is about: The mRNA-produced vaccines are now being tested in lung and breast cancers
TSX futures fall as gold slips
Futures for Canada's main stock index inched lower on Tuesday on weakness in bullion, while solid earnings from Canadian banks and higher crude prices limited the losses. … | August 24, 2021
Morning Update: Catholic Church charity set up to pay survivors of residential schools spent $6.46-million on expenses, records show
Plus, new dangers await Afghan evacuees making their way on foot to Turkey, while those hoping to get on Canadian flights say they aren’t getting sufficient information from officials
60 Biggest Movers From Yesterday
Gainers Trillium Therapeutics Inc. (NASDAQ:TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pf…
Trillium Therapeutics Aktie – Starkes Kursplus dank Pfizer-Übernahme
Trillium Therapeutics Aktie steigt um 184,51 %, nachdem bekannt wurde, dass Pfizer das Unternehmen kauft. Lohnt sich noch ein Einstieg?
Pfizer to acquire cancer drugmaker Trillium for $2.3 billion
It invested $25 million in Trillium in September as part of its ‘Breakthrough Growth Initiative’
Commodore Capital Lp Buys Celcuity Inc, C4 Therapeutics Inc, Cytokinetics Inc, Sells , Trillium Therapeutics Inc, Relmada Therapeutics Inc
GuruFocus Article or News written by insider and the topic is about:
Wall St gains, Nasdaq notches record closing high on full vaccine approval
Wall Street rallied on Monday, and the Nasdaq reached an all-time closing high as sentiment was boosted by full FDA approval of a COVID-19 vaccine and market participants looked ahead to the Jackson Hole Symposium expected to convene later this week. All three major U.S. stock indexes ended the session sharply higher, with the S&P 500 in the session's final minutes just failing to hold what would have been a record-high close.
TSX Ends On Strong Note As Energy, Materials Shares Rally
(RTTNews) – The Canadian stock market closed notably higher on Monday, lifted by strong gains in energy, materials and healthcare shares. Firm co…
TSX rises 0.68% to 20,477.26
* The Toronto Stock Exchange's TSX rises 0.68 percent to 20,477.26
* Leading the index were Trillium Therapeutics Inc , up 184.5%, MAG Silver Corp, up 8.3%, and New Gold… | August 23, 2021
Evening Update: Health care debate takes over federal election campaign
Also: Canada will support G7 sanctions against the Taliban, Trudeau says
U.S. Stocks Close On Firm Note
(RTTNews) – U.S. stocks closed on a strong note on Monday with several counters from across various sectors attracting buyers. Firm commodity pri…
U.S. Stocks Close On Firm Note
U.S. stocks closed on a strong note on Monday with several counters from across various sectors attracting buyers..
Trillium, Analog Devices rise: General Motors, Lennar fall
Stocks that traded heavily or had substantial price changes Monday: Trillium, Analog Devices rise; General Motors, Lennar fall
ROUNDUP/Aktien New York Schluss: Erholung verhilft Nasdaq und S&P zu Rekorden
ROUNDUP/Aktien New York Schluss: Erholung verhilft Nasdaq und S&P zu Rekorden | Nachricht | finanzen.net
Aktien New York Schluss: Erholung verhilft Nasdaq und S&P zu Rekorden
An den US-Börsen ist die am Freitag begonnene Erholung zu Wochenbeginn weiter gegangen. Händlern zufolge greifen die Anleger auf dem ermässigten Kursniveau neuerdings wieder etwas beherzter zu – und die Wahl fiel dabei…
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.61% By Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.61%
US stocks close at fresh records amid FDA approval of COVID-19 vaccine
Xinhua/Wang Ying/ Getty Images US stocks closed at record highs on Monday amid the FDA's approval of Pfizer's COVID vaccine.The S&…
Moderna : S&P 500, Nasdaq on course for record closing highs on vaccine boost
Wall Street rallied on Monday,
coming off a tumultuous week as investors digested full FDA
approval of a COVID-19 vaccine and looked ahead to the Jackson
Hole Symposium expected to convene later this… | August 23, 2021
Mid-Afternoon Market Update: Dow Gains 270 Points; Vivos Therapeutics Shares Spike Higher
Toward the end of trading Monday, the Dow traded up 0.77% to 35,392.00 while the NASDAQ rose 1.64% to 14,956.54. The S&P also rose, gaining 1….
S&P 500, Nasdaq on course for record closing highs on vaccine boost
NEW YORK — Wall Street rallied on Monday, coming off a tumultuous week as investors digested full FDA approval of a COVID-19 vaccine and looked ahead to the…
Canadian Market Firmly Up In Positive Territory; Trillium Therapeutics Skyrockets
(RTTNews) – The Canadian stock market is up firmly in positive territory Monday afternoon, riding on strong gains in healthcare, energy and materi…
S&P 500, Nasdaq Ride Energy, Tech Rally to Record Highs By Investing.com
S&P 500, Nasdaq Ride Energy, Tech Rally to Record Highs
Pfizer to acquire Canadian cancer drugmaker Trillium for $2.3 billion
Trillium shares nearly triple on news
Mid-Day Market Update: Crude Oil Surges 5%; Staffing 360 Solutions Shares Plunge
Midway through trading Monday, the Dow traded up 0.77% to 35,391.72 while the NASDAQ rose 1.35% to 14,912.95. The S&P also rose, gaining 0.95% to …
Trillium Therapeutics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Trillium Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact th
Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Trillium Therapeutics Inc. to Pfizer Inc. for $18.50 per share in cash is fair to Trillium… | August 23, 2021